Two years follow-up of an open-label pilot study of treatment with rituximab in patients with early diffuse cutaneous systemic sclerosis.
Melsens K, Vandecasteele E, Deschepper E, Badot V, Blockmans D, Brusselle G, De Langhe E, De Pauw M, Debusschere C, Decuman S, Deroo L, Houssiau F, Lenaerts J, Piette Y, Thevissen K, Vanthuyne M, Westhovens R, Wijnant S, De Keyser F, Smith V.
Melsens K, et al. Among authors: badot v.
Acta Clin Belg. 2018 Apr;73(2):119-125. doi: 10.1080/17843286.2017.1372244. Epub 2017 Sep 11.
Acta Clin Belg. 2018.
PMID: 28891418